Medi Assist Health Ser L
NSE: MEDIASSIST
Prev Close
396.4
Open Price
396.4
Volume
100,550
Today Low / High
386.4 / 397
52 WK Low / High
385 / 594.1
Range
369 - 407
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 388, with a change of -8.4 (-2.11907%). The expected target range on the NSE is between 369 - 407. The stock is experiencing a downward trend on the NSE. Investors should be cautious as the price is currently declining.
Medi Assist Health Ser L Graph
Medi Assist Health Ser L Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Medi Assist Health Ser L T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 388.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 388.00 | 391.88 | 352.69 - 431.07 |
| 395.76 | 316.61 - 474.91 | ||
| 399.64 | 279.75 - 519.53 | ||
| Bearish Scenario | 388.00 | 384.12 | 345.71 - 422.53 |
| 380.24 | 304.19 - 456.29 | ||
| 376.36 | 263.45 - 489.27 |
Overview of Medi Assist Health Ser L
ISIN
INE456Z01021
Industry
Investment - Banking & Investment Services
Vol.Avg
161,739
Market Cap
28,889,603,120
Last Dividend
4
Official Website
IPO Date
2024-01-23
DCF Diff
-209.57
DCF
600
Financial Ratios Every Investor Needs
Stock Dividend of MEDIASSIST
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-06 | September 06, 24 | 4 | 4 | 2024-09-06 | 2024-10-20 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 723.32 Cr | 305.86 Cr | 417.46 Cr | 0.5771 | 0.00 Cr | 5.90 Cr | 98.33 Cr | 90.88 Cr | 12.91 | 177.87 Cr | 0.1256 |
| 2024-03-31 | 634.73 Cr | 372.70 Cr | 262.02 Cr | 0.4128 | 0.00 Cr | 45.98 Cr | 95.90 Cr | 66.94 Cr | 9.71 | 130.63 Cr | 0.1055 |
| 2023-03-31 | 504.93 Cr | 293.21 Cr | 211.72 Cr | 0.4193 | 0.00 Cr | 29.99 Cr | 104.29 Cr | 74.06 Cr | 10.76 | 133.34 Cr | 0.1467 |
| 2022-03-31 | 393.81 Cr | 195.71 Cr | 198.10 Cr | 0.5030 | 0.00 Cr | 23.03 Cr | 65.62 Cr | 64.22 Cr | 9.33 | 112.05 Cr | 0.1631 |
| 2021-03-31 | 322.74 Cr | 210.75 Cr | 111.99 Cr | 0.3470 | 0.00 Cr | 20.44 Cr | 66.81 Cr | 26.27 Cr | 3.92 | 97.46 Cr | 0.0814 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 83.01 Cr | 1,158.23 Cr | 606.07 Cr | 541.4700 Cr | 203.69 Cr | 120.68 Cr | 0.00 Cr | 84.01 Cr | 0.00 Cr | 0.00 Cr | 25.70 Cr | 504.2590 Cr |
| 2024-03-31 | 50.93 Cr | 850.58 Cr | 369.25 Cr | 471.7420 Cr | 26.33 Cr | -24.60 Cr | 24.71 Cr | 55.11 Cr | 0.00 Cr | 0.00 Cr | 7.87 Cr | 319.4570 Cr |
| 2023-03-31 | 56.21 Cr | 705.72 Cr | 322.04 Cr | 376.6110 Cr | 30.68 Cr | -23.27 Cr | 0.00 Cr | 54.29 Cr | 171.34 Cr | 0.00 Cr | -111.02 Cr | 278.5360 Cr |
| 2022-03-31 | 14.60 Cr | 602.23 Cr | 262.94 Cr | 337.1290 Cr | 27.48 Cr | 12.88 Cr | 0.00 Cr | 41.34 Cr | 153.70 Cr | 0.00 Cr | -226.93 Cr | 234.2030 Cr |
| 2021-03-31 | 63.39 Cr | 545.30 Cr | 252.75 Cr | 290.3880 Cr | 35.30 Cr | -28.04 Cr | 0.00 Cr | 56.80 Cr | 128.36 Cr | 0.00 Cr | 7.53 Cr | 218.5180 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 138.0860 Cr | -218.2440 Cr | 112.0720 Cr | 92.2930 Cr | 32.0870 Cr | 83.0140 Cr | -45.7930 Cr | 90.8790 Cr | 150.0770 Cr | -28.1350 Cr | 0.0000 Cr |
| 2024-03-31 | 66.3810 Cr | -54.8640 Cr | -14.7550 Cr | 47.9570 Cr | -3.0170 Cr | 50.9270 Cr | -18.4240 Cr | 81.6380 Cr | -0.0770 Cr | -13.0140 Cr | 0.0000 Cr |
| 2023-03-31 | 81.0790 Cr | -10.4880 Cr | -31.5250 Cr | 53.4100 Cr | 39.3490 Cr | 53.9440 Cr | -27.6690 Cr | 101.9170 Cr | -4.2830 Cr | -13.0140 Cr | 0.0000 Cr |
| 2022-03-31 | 64.4760 Cr | -82.8990 Cr | -30.3710 Cr | 52.7030 Cr | -48.7940 Cr | 14.5950 Cr | -6.0060 Cr | 81.6910 Cr | -12.9590 Cr | -17.2150 Cr | 0.0000 Cr |
| 2021-03-31 | 135.2020 Cr | -55.5990 Cr | -10.7580 Cr | 121.9480 Cr | 68.8450 Cr | 63.3890 Cr | -13.2540 Cr | 45.9880 Cr | -0.2000 Cr | 0.0000 Cr | 0.0000 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 239.68 Cr | 216.19 Cr | 23.49 Cr | 0.0980 | 23.49 Cr | 4.17 Cr | 0.56 | 37.99 Cr | 0.0174 |
| 2025-09-30 | 232.55 Cr | 105.45 Cr | 127.10 Cr | 0.5465 | 18.79 Cr | 7.95 Cr | 1.13 | 41.99 Cr | 0.0342 |
| 2025-06-30 | 190.56 Cr | 79.86 Cr | 110.69 Cr | 0.5809 | 27.90 Cr | 22.40 Cr | 3.18 | 49.40 Cr | 0.1175 |
| 2025-03-31 | 188.87 Cr | 78.92 Cr | 109.95 Cr | 0.5821 | 26.64 Cr | 21.49 Cr | 3.05 | 48.51 Cr | 0.1138 |
| 2024-12-31 | 185.97 Cr | 79.01 Cr | 106.97 Cr | 0.5752 | 25.27 Cr | 29.53 Cr | 4.20 | 44.12 Cr | 0.1588 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 55.78 Cr | 176.53 Cr | 232.31 Cr | 338.20 Cr | 0.00 Cr | 615.01 Cr | 96.80 Cr | 1,420.00 Cr | 828.85 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 456.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -552.16 Cr |
| 2025-03-31 | 83.01 Cr | 354.58 Cr | 437.59 Cr | 221.36 Cr | 0.00 Cr | 751.38 Cr | 84.01 Cr | 1,158.23 Cr | 606.07 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 335.19 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -498.54 Cr |
| 2024-09-30 | 248.12 Cr | 87.07 Cr | 335.19 Cr | 214.14 Cr | 0.00 Cr | 621.81 Cr | 88.17 Cr | 1,068.96 Cr | 570.42 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 22.40 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 21.49 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 29.53 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 21.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 18.82 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Investment - Banking & Investment Services
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Medi Assist Health Ser L | MEDIASSIST | ₹388.00 | ₹28,889,603,120.00 | ₹100,550.00 |
Key Executives
Gender: Not Specified
Year Born:
Gender: Not Specified
Year Born: 1969
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1983
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1968
Gender: male
Year Born: 1977
Gender: female
Year Born:
FAQs about Medi Assist Health Ser L
The CEO is Satish Gidugu.
The current price is ₹388.00.
The range is ₹385-594.1.
The market capitalization is ₹2,888.96 crores.
The P/E ratio is 51.59.
The company operates in the Financial Services sector.
Overview of Medi Assist Health Ser L (ISIN: INE456Z01021) is a leading Investment - Banking & Investment Services in India. With a market capitalization of ₹2,888.96 crores and an average daily volume of 161,739 shares, it operates in the Investment - Banking & Investment Services. The company last declared a dividend of ₹4.